Respiratory syncytial virus (RSV) disease in hospitalised adults in Europe with COPD: Impact of GOLD score on RSV disease burden
T. Harrer (Paris, France), F. Thalhammer (Vienna, Austria), O. Launay (Erlangen, Germany), A. Cheret (Issy-les-Moulineaux, France), G. De La Rosa (Raritan, United States of America), I. Sander (Cambridge, United States of America), R. Stolper (Cambridge, United States of America), J. Zakar (Cambridge, United States of America), K. Weber (Vienna, Austria)
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Disease area: Respiratory critical care
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Harrer (Paris, France), F. Thalhammer (Vienna, Austria), O. Launay (Erlangen, Germany), A. Cheret (Issy-les-Moulineaux, France), G. De La Rosa (Raritan, United States of America), I. Sander (Cambridge, United States of America), R. Stolper (Cambridge, United States of America), J. Zakar (Cambridge, United States of America), K. Weber (Vienna, Austria). Respiratory syncytial virus (RSV) disease in hospitalised adults in Europe with COPD: Impact of GOLD score on RSV disease burden. 5309
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: